Neurology 1110 - Neurology Alert - Oct 01, 2007

Target Audience:

This activity is intended for the neurologist.


AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Matthew Fink, MD

Vice Chairman
Professor of Clinical Neurology
Weill Medical College
Chief of Division of Stroke and Critical Care Neurology
NewYork Presbyterian Hospital

Assistant Editors
Alan Z. Segal, MD
Assistant Professor
Department of Neurology
Weill-Cornell Medical College
Attending Neurologist
NewYork Presbyterian Hospital

Dana Leifer, MD
Associate Professor
Clinical Neurology
Weill Medical College
Cornell University

Michael Rubin, MD
Professor of Clinical Neurology
NewYork Presbyterian Hospital
Cornell Campus

Dara G. Jamieson, MD
Associate Professor
Clinical Neurology Director
Weill Medical College
Cornell University

Peer Reviewer
M. Flint Beal, MD
Professor and Chairman
Department of Neurology
Cornell University Medical College
New York, NY

Padmaja Kandula, MD
Assistant Professor of Neurology and Neuroscience
Comprehensive Epilepsy Center
Weill Medical College
Cornell University

Melissa J. Nirenberg, MD, PhD
Assistant Professor
Neurology and Neuroscience
Weill Cornell Medical College


  • Statin Withdrawal May Lead to Adverse Outcomes in Acute Stroke
  • Dementia with Lewy Bodies vs Parkinson's Disease with Dementia: Different Patterns of Cortical Atrophy
  • Telemedicine for Stroke: An Idea Whose Time Has Come
  • "Peroneal Tunnel" Neuropathy?
  • What Causes Cognitive Impairment After Coronary Bypass Surgery?
  • On the Origin of PLEDs: Are Cortical and Subcortical PLEDs Electrographically Different?
  • Young Woman — Do Not Visualize Your Migraine Aura Through Cigarette Smoke!


  • Present current scientific data regarding diagnosis and treatment of neurologic disease, including stroke, Alzheimer?s disease, transient ischemic attack, and coma
  • Discuss the pathogenesis and treatment of pain
  • Present basic science lessons in brain function
  • Discuss information regarding new drugs for commonly diagnosed diseases and new uses for traditional drugs
  • Discuss nonclinical issues of importance to neurologists, such as the right to die and the physician?s legal obligation to patients with terminal illness

Financial Disclosure:

Neurology Alert’s physician editor, Matthew Fink, MD, assistant editor Dana Leifer, MD, peer reviewer M. Flint Beal, MD, and author Padmaja Kandula, MD, report no consultant, stockholder, speaker’s bureau, research, or other financial relationship with any company having ties to this field of study. Assistant Editor Alan Z. Segal, MD is on the speaker’s bureau for Boehringer-Ingelheim. Assistant Editor Michael Rubin, MD is on the speaker’s bureau for Athena Diagnostics, and does research for Pfizer and Merck. Assistant editor Dara G. Jamieson, MD, is a consultant for Boehringer Ingelheim and Merck, and is on the speaker's bureau for Boehringer Ingelheim, Merck, Ortho-McNeil, and Pfizer. Author Melissa J. Nirenberg, MD, PhD, does research for Boehringer-Ingelheim.

Copyright 2007 AHC Media. All rights reserved.